Allen J.Y. (1996). Antiphospholipid antibodies in patients with pre-eclampsia . Am J Repro Immunol; 36, 81-85
2.
Cooper D.W., Hill J.A., Chesley L.C. and Bryans C.I. (1988). Genetic control of the susceptibility to pre-eclampsia and miscarriage. Br J Obstet Gynaecol; 95, 644-653
3.
El-Roeiy A., Myers S.A. and Gleicher N. (1991). The relationship between autoantibodies and intrauterine growth retardation in hypertensive disorders of pregnancy. Am J Obstet Gynecol; 164, 1253-1261
4.
Kilpatrick D.C., Liston W.A., Gibson F. and Livingstone J. (1989). Association between susceptibility to pre-eclampsia within families and HLA DR4. Lancet;ii, 1063-1065
5.
Klonoff-Cohen H.S., Savitz D.A., Cefalo R.C. and Mccann M.F. (1989). An epidemiologic study of contraception and pre-eclampsia . J Am Med Ass; 262, 3143-3147
6.
Redman C W G (2001). Lecture at the Annual British Maternal and Fetal Medicine Society Meeting, Warwick University, Coventry, 22-23 March 2001
7.
Robillard P-Y. and Hulsey T.C. (1996). Association of pregnancy induced hypertension, pre-eclampsia, and eclampsia with duration of sexual cohabitation before conception. Lancet, 347, 619
8.
Robillard P-Y., Hulsey T.C., Perianin J., Janky E., Miri E.H. and Papiernik E. (1994). Association of pregnancy induced hypertension with duration of sexual cohabitation before conception. Lancet; 344, 973-975
9.
Salas S.P. (1999). What causes pre-eclampsia. Best Pract Res Clin Obstet Gynaecol; 13(1), 41-57
10.
Seligman S., Buyon J., Clancy R., Young B.K. and Abramson S.B. (1994). The role of nitric oxide in the pathogenesis of pre-eclampsia. Am J Obstet Gynecol; 171, 944-948
11.
Taylor R.N. (1997). Review: immunobiology of pre-eclampsia. Am J Repro Immunol; 37, 79-86
